Institut für Versorgungsforschung in der Onkologie
- Research works
- 77 ▲ 38% vs 2013–17
- Citations
- 664 8.7 per fractional work
- Top-10% rate
- 15.7% record average 16.5%
- Open access
- 14% world 28%
Not ranked overall: Institut für Versorgungsforschung in der Onkologie is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Business, Management and Accounting, 3.7×. Every wedge is a field page.
Which keywords describe research at Institut für Versorgungsforschung in der Onkologie?
By fractional works in all years, weighted toward what it does more of than the world: Rituximab, Immunotherapy, Prognostic Factors, Chemotherapy, Gene Expression Profiling, Molecular Profiling, Quality of Life and Genetic Mutations.
- Quality
- Pancreatic Cancer
- Rehabilitation
- Breast Cancer
- Metastasis
- Neoadjuvant Therapy
- Genomic Aberrations
- Therapeutic Targets
- Patient-Reported Outcomes
- Comet Assay
- Cancer Survivorship
- Oxidative Stress
- Sustainable Development
- Lymphoma
- Genetic Pathogenesis
- Health-related Quality of Life
- Classification
- Gene Expression Profiling
- Chemotherapy
- Immunotherapy
- Rituximab
- Quality of Life
- Prognostic Factors
- Molecular Profiling
- Genetic Mutations
- PET Imaging
- Hodgkin's Lymphoma
- Risk Assessment
- DNA Damage
- Biomonitoring
- Clinical Trials
- Genotoxicity Testing
- Cancer
- Chronic Lymphocytic Leukemia
- Metastatic Breast Cancer
- Health Effects
- Radiotherapy
- Environmental Exposure
- Genomic Profiling
- Patient Care
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Rituximab6▲ 45×2 topics
- Immunotherapy5▲ 10×10 topics
- Quality of Life5▲ 4.6×6 topics
- Chemotherapy4▲ 8.1×11 topics
- Prognostic Factors4▲ 13×8 topics
- Gene Expression Profiling4▲ 56×2 topics
- Molecular Profiling4▲ 46×2 topics
- Classification3▲ 12×3 topics
- Genetic Mutations3▲ 8.6×7 topics
- Health-related Quality of Life3▲ 21×4 topics
- PET Imaging3▲ 20×3 topics
- Genetic Pathogenesis3▲ 69×1 topic
- Hodgkin's Lymphoma3▲ 69×1 topic
- Lymphoma3▲ 28×2 topics
- Risk Assessment3▲ 7.0×2 topics
- Sustainable Development3▲ 3.6×6 topics
- DNA Damage3▲ 30×2 topics
- Oxidative Stress3▲ 2.1×12 topics
- Biomonitoring3▲ 31×2 topics
- Cancer Survivorship3▲ 61×1 topic
- Clinical Trials3▲ 5.8×5 topics
- Comet Assay3▲ 81×1 topic
- Genotoxicity Testing3▲ 81×1 topic
- Patient-Reported Outcomes3▲ 97×1 topic
- Cancer3▲ 2.5×12 topics
- Therapeutic Targets2▲ 14×3 topics
- Chronic Lymphocytic Leukemia2▲ 62×1 topic
- Genomic Aberrations2▲ 62×1 topic
- Metastatic Breast Cancer2▲ 44×2 topics
- Neoadjuvant Therapy2▲ 12×2 topics
- Health Effects2▲ 4.3×4 topics
- Metastasis2▲ 7.5×3 topics
- Radiotherapy2▲ 6.8×6 topics
- Breast Cancer2▲ 8.8×4 topics
- Environmental Exposure2▲ 22×2 topics
- Rehabilitation2▲ 5.9×2 topics
- Genomic Profiling2▲ 22×2 topics
- Pancreatic Cancer2▲ 18×3 topics
- Patient Care2▲ 21×1 topic
- Quality2▲ 41×1 topic
Which research topics does Institut für Versorgungsforschung in der Onkologie publish most on?
By volume in 2022–2025: Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Corporate Social Responsibility and Sustainability and Public Relations and Crisis Communication.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
- 2 HER2/EGFR in Cancer Research Oncology 0 works
- 3 Corporate Social Responsibility and Sustainability Organizational Behavior and Human Resource Management 0 works
- 4 Public Relations and Crisis Communication Communication 0 works
- 5 Corporate Management and Leadership Organizational Behavior and Human Resource Management 0 works
- 6 Breast Cancer Treatment Studies Cancer Research 0 works
- 7 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
- 8 Clinical Reasoning and Diagnostic Skills Family Practice 0 works
- 9 Brain Metastases and Treatment Pulmonary and Respiratory Medicine 0 works
- 10 Lung Cancer Research Studies Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Institut für Versorgungsforschung in der Onkologie's research output changed?
Output in 2018–2022 was 38% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Koblenz
- Koblenz University of Applied Sciences
- Bundeswehrzentralkrankenhaus Koblenz
- Federal Institute of Hydrology
- Landesuntersuchungsamt Rheinland-Pfalz
- Gemeinschaftsklinikum Mittelrhein
- Katholisches Klinikum Koblenz
- Federal Office of Bundeswehr Equipment, Information Technology and In-Service Support
- Wehrwissenschaftliches Institut für Werk- und Betriebsstoffe
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.